Keyphrases
Carotid Endarterectomy
100%
Ischemic Stroke
83%
Intracranial Hemorrhage
50%
Cerebrovascular Disease
50%
Natural Outcome
50%
Maximal Medical Therapy
50%
Vascular Neurology
50%
Ethnic Diversity
50%
Vision Loss
50%
Treatment Strategy
50%
Intracerebral Hemorrhage
50%
Carotid Artery Stenosis
50%
Sectional Analysis
50%
Hearing Impairment
50%
Spontaneous Intracerebral Hemorrhage
50%
Natural History
50%
Racial Diversity
50%
Visual Loss
50%
Visual Pathway
50%
Acute Treatment
50%
Neurology Resident
42%
Statins
39%
Symptomatic Stenosis
33%
Secondary Prevention
33%
Antiplatelet Agents
25%
Older Men
25%
Differential Diagnosis
25%
Neuro-ophthalmology
25%
Clinical Approach
25%
Bilateral Sensorineural Hearing Loss
25%
Ophthalmology Clinic
25%
Homonymous Hemianopia
25%
Underrepresented in Medicine
21%
Surgical Risk
16%
Severe Stenosis
16%
Risk Factor Management
16%
Three-level
16%
Carotid Intervention
16%
Treatment Decisions
16%
Carotid Stenosis
16%
Surgical Complications
16%
Stroke Prevention
16%
Carotid Stenting
16%
Symptomatic Patients
16%
Retinal Stroke
16%
Severe Aortic Stenosis
16%
Central Retinal Artery Occlusion
16%
Cerebral Stroke
16%
Retinal Artery Occlusion
16%
Hemispheric Stroke
16%
Medicine and Dentistry
Visual Impairment
100%
Apoplexy
75%
Vascular Neurology
50%
Cross Sectional Study
50%
Stenosis
50%
Hearing Impairment
50%
Carotid Artery Stenosis
50%
Cerebral Hemorrhage
50%
Neurology
42%
Carotid Endarterectomy
37%
Visual Pathway
30%
Neuro-Ophthalmology
25%
Differential Diagnosis
25%
Sensorineural Hearing Loss
25%
Medical Decision Making
25%
Homonymous Hemianopsia
25%
Brain Ischemia
22%
Medicine
21%
Secondary Prevention
20%
Recurrent Disease
12%
Statin
12%
Carotid Artery Surgery
12%
Carotid Artery Stenting
12%
Postoperative Complication
12%
Surgical Risk
12%
Internal Carotid Artery
12%
Antiplatelet Drug
12%
Retina Artery Occlusion
10%
Ischemic Optic Neuropathy
10%
Central Retinal Artery Occlusion
10%
Rehabilitation Engineering
10%
Prophylaxis
10%
Ischemia
10%
Apolipoprotein E
6%
Relative Risk Reduction
6%
Perindopril
6%
Gene Insertion
6%
Factor XIII
6%
Risk Reduction
6%
Alcohol Consumption
6%
Blood Pressure
6%
Leukoaraiosis
6%
Clinical Trial
6%
Bleeding
6%
Hematoma
6%
Endoglin
6%
Allele
6%
Heredity
6%
